● Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Condition: Epithelial Ovarian Cancer · Primary Peritoneal · Fallopian Tube Cancer · Sponsor: TORL Biotherapeutics, LLC

PhasePhase 2

Planned participants230

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Hatem Dokainish, PhD · 310-348-9636 · CATALINA-2-Study@torlbio.com

Always discuss trial participation with your own doctor first.

Locations (66)

Mayo Clinic Hospital	Phoenix, Arizona, United States	Recruiting
SCRI - Arizona Oncology Associates, PC-HOPE	Tucson, Arizona, United States	Recruiting
City of Hope National Medical Center	Duarte, California, United States	Recruiting
Providence St. Jude Medical Center	Fullerton, California, United States	Recruiting
UCLA - JCCC Clinical Research Unit	Los Angeles, California, United States	Recruiting
Stanford Cancer Center	Palo Alto, California, United States	Recruiting
SCRI - Sansum Clinic	Santa Barbara, California, United States	Recruiting
Smilow Cancer Hospital at Yale - New Haven	New Haven, Connecticut, United States	Recruiting
Mayo Clinic Florida	Jacksonville, Florida, United States	Recruiting
Winship Cancer Institute, Emory University	Atlanta, Georgia, United States	Recruiting
University of Chicago Medical Center	Chicago, Illinois, United States	Recruiting
SCRI - Maryland Oncology Hematology, P.A.	Annapolis, Maryland, United States	Recruiting

+ 54 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06690775